ENDOMETRIAL THINNING

This adverse event was reported 35 times

ENDOMETRIAL THINNING is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) 5 0.0022
1 PENTOXIFYLLINE 2 0.0005
2 TRANEXAMIC ACID 4 0.0004
3 ETONOGESTREL 9 0.0002
4 LEVONORGESTREL 19 0.0001
5 VITAMIN E 2 0.0001
6 HUMAN IMMUNOGLOBULIN G 1 0.0000
7 COPPER 2 0.0000
8 PROGESTERONE 1 0.0000
9 ERGOCALCIFEROL 1 0.0000
See all drugs enriched for association with ENDOMETRIAL THINNING

ENDOMETRIAL THINNING is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Blood Viscosity Reducer [EPC] 2 0.0005
1 Antifibrinolytic Agent [EPC] 4 0.0004
2 Progestin [EPC] 28 0.0001
3 Human Immunoglobulin G [EPC] 1 0.0000
4 Progesterone [EPC] 1 0.0000
5 Copper-containing Intrauterine Device [EPC] 2 0.0000
6 Estrogen [EPC] 5 0.0000
7 Platelet Aggregation Inhibitor [EPC] 4 0.0000
8 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
9 Vitamin C [EPC] 2 0.0000
See all drug classes enriched for association with ENDOMETRIAL THINNING